How data is crucial to the relaunch of the Cancer Moonshot
pharmaphorum
OCTOBER 4, 2022
During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). As part of the relaunch, a goal was set to reduce the death rate from cancer by at least 50% over the next 25 years.
104 
Let's personalize your content